Evidence map›Paper›PMID 36219457›Full record

ArticleCardiovascular research2023

Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension.

Aletta E Schutte, Tazeen H Jafar, Neil R Poulter, Albertino Damasceno, Nadia A Khan, Peter M Nilsson, Jafar Alsaid, Dinesh Neupane, Kazuomi Kario, Hind Beheiry and 29 more

Abstract read
In one paragraph

Article in Cardiovascular research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Home-Based Care for Hypertension in Rural South Africa.The New England journal of medicine · 2025
    Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Global trends in hypertension prevalence, awareness, treatment, and control.Current opinion in nephrology and hypertension · 2026
    Review
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

Aletta E SchutteSchool of Population Health, University of New South Wales, Kensington Campus, High Street, Sydney 2052 NSW, Australia; The George Institute for Global Health, King Street, Newton, Sydney NSW 2052, Australia.ORCID 0000-0001-9217-4937
Tazeen H JafarProgram in Health Services and Systems Research, Duke-NUS Medical School, Department of Renal Medicine, 8 College Rd., Singapore 169857, Singapore.ORCID 0000-0001-7454-8376
Neil R PoulterImperial Clinical Trials Unit, School of Public Health, Imperial College London, London W12 7RH, UK.ORCID 0000-0002-6292-997X
Albertino DamascenoFaculty of Medicine, Eduardo Mondlane University, 3453 Avenida Julius Nyerere, Maputo, Mozambique.ORCID 0000-0002-5547-0224
Nadia A KhanDepartment of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Peter M NilssonDepartment of Clinical Sciences, Skane University Hospital, Lund University, Malmö, Sweden.ORCID 0000-0002-5652-8459
Jafar AlsaidOchsner Health System, New Orleans, Louisiana, USA.ORCID 0000-0002-0269-5630
Dinesh NeupaneDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0002-1501-2990
Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0002-8251-4480
Hind BeheiryInternational University of Africa, Khartoum, Sudan.ORCID 0000-0001-6905-1867
Sofie BrouwersDepartment of Cardiology, Cardiovascular Center Aalst, OLV Clinic Aalst, Aalst, Belgium.ORCID 0000-0002-7081-4881
Dylan BurgerKidney Research Centre, Ottawa Hospital Research Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.ORCID 0000-0003-3951-2911
Fadi J CharcharHealth Innovation and Transformation Centre, Federation University, Ballarat, Victoria, Australia.ORCID 0000-0002-6164-9941
Myeong-Chan ChoDepartment of Internal Medicine, College of Medicine, Chungbuk National University, Cheongju, Korea.ORCID 0000-0002-0047-0227
Tomasz J GuzikInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.ORCID 0000-0002-5039-7849
Ghazi F Haji Al-SaediBaghdad College of Medicine, Baghdad, Iraq.ORCID 0000-0001-5261-3106
Muhammad IshaqPakistan Hypertension League, Karachi, Pakistan.ORCID 0000-0001-9725-2164
Hiroshi ItohDepartment of Endocrinology, Metabolism and Nephrology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8585, Japan.ORCID 0000-0003-2514-4919
Erika S W JonesDivision of Nephrology and Hypertension, Groote Schuur Hospital and Kidney and Hypertension Research Unit, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-3569-3498
Taskeen KhanDepartment of Public Health Medicine, University of Pretoria, Pretoria, South Africa.ORCID 0000-0002-1676-4895
Yoshihiro KokuboDepartment of Preventive Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan.ORCID 0000-0002-0705-9449
Praew KotruchinDepartment of Emergency Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.ORCID 0000-0003-3519-3415
Elizabeth MuxfeldtUniversity Hospital Clementino Fraga Filho, Hypertension Program, Universidade Federal do Rio de Janeiro, Brazil.ORCID 0000-0003-3853-7842
Augustine OdiliCirculatory Health Research Laboratory, College of Health Sciences, University of Abuja, Abuja, Nigeria.ORCID 0000-0002-4564-1587
Mansi PatilDepartment of Nutrition and Dietetics, Asha Kiran JHC Hospital, Chinchwad, India.ORCID 0000-0002-2337-385X
Udaya RalapanawaFaculty of Medicine, University of Peradeniya, Kandy, Central Province, Sri Lanka.ORCID 0000-0002-7416-7984
Cesar A RomeroRenal Division, Department of Internal Medicine, Emory University School of Medicine, Atlanta, GA, USA.ORCID 0000-0002-8445-9665
Markus P SchlaichDobney Hypertension Centre, School of Medicine, Royal Perth Hospital Unit and RPH Research Foundation, The University of Western Australia, Perth, Australia.ORCID 0000-0002-1765-0195
Abdulla ShehabCollege of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.ORCID 0000-0001-8533-9174
Ching Siew MooiDepartment of Family Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia.ORCID 0000-0002-4425-7989
U Muscha SteckelingsDepartment of Cardiovascular & Renal Research, Institute of Molecular Medicine. University of Southern Denmark, Odense, Denmark.ORCID 0000-0002-5430-4275
George StergiouHypertension Centre STRIDE-7, School of Medicine, Third Department of Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Athens, Greece.ORCID 0000-0002-6132-0038
Rhian M TouyzResearch Institute of the McGill University Health Centre, McGill University, Montreal, QC, Canada.ORCID 0000-0003-0670-0887
Thomas UngerCARIM - Cardiovascular Research Institute, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-0233-8705
Richard D WainfordDepartment of Pharmacology & Experimental Therapeutics and the Whitaker, Cardiovascular Institute, Boston University School of Medicine, Boston, MA, USA.ORCID 0000-0003-2830-5618
Ji-Guang WangDepartment of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0001-8511-1524
Bryan WilliamsInstitute of Cardiovascular Science, University College London (UCL), National Institute for Health Research (NIHR), UCL Hospitals Biomedical Research Centre, London, UK.ORCID 0000-0002-8094-1841
Brandi M WynneDepartment of Internal Medicine, Division of Nephrology & Hypertension, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0003-0861-4245
Maciej TomaszewskiDivision of Cardiovascular Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK.ORCID 0000-0001-8215-6567

Funding

British Heart FoundationMedical Research Council MR/L004224/1Medical Research Council MR/N006178/1MRF_ MRF-145-0008-DG-JAFA-C0862
6 · The paper itself

Abstract

abstractRaised blood pressure (BP) is the leading cause of preventable death in the world. Yet, its global prevalence is increasing, and it remains poorly detected, treated, and controlled in both high- and low-resource settings. From the perspective of members of the International Society of Hypertension based in all regions, we reflect on the past, present, and future of hypertension care, highlighting key challenges and opportunities, which are often region-specific. We report that most countries failed to show sufficient improvements in BP control rates over the past three decades, with greater improvements mainly seen in some high-income countries, also reflected in substantial reductions in the burden of cardiovascular disease and deaths. Globally, there are significant inequities and disparities based on resources, sociodemographic environment, and race with subsequent disproportionate hypertension-related outcomes. Additional unique challenges in specific regions include conflict, wars, migration, unemployment, rapid urbanization, extremely limited funding, pollution, COVID-19-related restrictions and inequalities, obesity, and excessive salt and alcohol intake. Immediate action is needed to address suboptimal hypertension care and related disparities on a global scale. We propose a Global Hypertension Care Taskforce including multiple stakeholders and societies to identify and implement actions in reducing inequities, addressing social, commercial, and environmental determinants, and strengthening health systems implement a well-designed customized quality-of-care improvement framework.

Indexed as

Cardiovascular DiseasesCOVID-19HypertensionBlood PressureHumansIncomeAwarenessCardiovascular diseaseControlEpidemiologyGlobalHypertensionInequityInternationalPreventionRegionsTreatment

Identifiers

PMID36219457
PMCPMC9619669

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.